Design and results of the phase 3 PERSIST-1 trial of pacritinib in myelofibrosis | Dr Ruben Mesa at Annual Meeting 2015 - 101271

Spotlight
Video

Design and results of the phase 3 PERSIST-1 trial of pacritinib in myelofibrosis | Dr Ruben Mesa at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Ruben A. Mesa, MD, Chair of Hematology at Mayo Clinic, Arizona, TX, discusses the trial design and results of the phase 3 PERSIST-1 trial of pacritinib, versus best available therapy in patients with primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia-myelofibrosis.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 06/23/15
Added : 3 years ago